RD-3-0028 is a potent and selective inhibitor of respiratory syncytial virus (RSV) replication, with an EC50 of 4.5 μM; it shows superior efficacy compared to ribavirin in vitro and in vivo; it significantly reduces pulmonary RSV titers in infected mice when administered as an aerosol; it protects lungs from virus-induced tissue damage by preserving lung architecture and reducing inflammatory infiltrates; it is non-toxic at therapeutic doses.